Drug Metabolism Letters
Volume 15, 3 Issues, 2022
ISSN: 1874-0758 (Online)
ISSN: 1872-3128 (Print)
This journal supports open access
ISSN: 1874-0758 (Online)
ISSN: 1872-3128 (Print)
This journal supports open access
Contents
Drug Metabolism Letters , Volume 11 - Number 1
Biography
Preface
Review Article
Obesity and Inflammation and Altered Clopidogrel Pharmacokinetics and Pharmacodynamics
, 11(1): 3 - 13Nicholas B. Norgard* and Scott V. Monte
DOI: 10.2174/1872312811666170301110349
Review Article
Metabolic Profile of Flunitrazepam: Clinical and Forensic Toxicological Aspects
, 11(1): 14 - 20Ricardo Jorge Dinis-Oliveira*
DOI: 10.2174/1872312811666170407164216
Research Article
Mixed Matrix Method Provides A Reliable Metabolite Exposure Comparison for Assessment of Metabolites in Safety Testing (MIST)
, 11(1): 21 - 28Ryan H. Takahashi, Cyrus Khojasteh, Matthew Wright, Cornelis E.C.A. Hop and Shuguang Ma*
DOI: 10.2174/1872312811666170710193229
Research Article
The Role of Placental Carbonyl Reducing Enzymes in Biotransformation of Bupropion and 4-methylnitrosamino-1-(3-pyridyl)-1-butanone
, 11(1): 29 - 34Valentina M. Fokina, Svetlana L. Patrikeeva, Cheryl Oncken, Gary D.V. Hankins, Mahmoud S. Ahmed and Tatiana Nanovskaya*
DOI: 10.2174/1872312811666170607095202
Research Article
Quantification of Sulfotransferases 1A1 and 1A3/4 in Tissue Fractions and Cell Lines by Multiple Reaction Monitoring Mass Spectrometry
, 11(1): 35 - 47Sho Yoshitake, Melissa McKay-Daily, Masaki Tanaka and Zeqi Huang*
DOI: 10.2174/1872312811666170731170153
Research Article
Inhibitory Effect of Fruit Juices on the Doxorubicin Metabolizing Activity of Carbonyl Reductase 1
, 11(1): 48 - 52Takeshi Miura*, Katsutoshi Nagai, Shingo Kaneshiro, Ayako Taketomi, Toshikatsu Nakabayashi, Hiroki Konishi, Toru Nishinaka and Tomoyuki Terada
DOI: 10.2174/1872312811666170309153025
Research Article
Potential Minor Haplotypes of CYP2D6 in the Japanese Population
, 11(1): 53 - 59Masatoshi Masuda*, Tsutomu Fujiwara, Masayuki Matsunaga and Takehisa Matsumaru
DOI: 10.2174/1872312811666170613080221
Letter Article
Gender Difference of Hepatic and Intestinal CYP3A4 in CYP3AHumanized Mice Generated by a Human Chromosome-engineering Technique
, 11(1): 60 - 67Kaoru Kobayashi*, Chihiro Abe, Mika Endo, Yasuhiro Kazuki, Mitsuo Oshimura and Kan Chiba
DOI: 10.2174/1872312811666170404153804
Letter Article
Effects of Fenofibrate on the Expression of Small Heterodimer Partner (SHP) and Cytochrome P450 (CYP) 2D6
, 11(1): 68 - 72Rebecca Kent and Hyunyoung Jeong*
DOI: 10.2174/1872312811666170407164631
Editor-in-Chief
Zhiyang Zhao
Alliance Pharma
Malvern, PA
(USA)
Biography
Alliance Pharma
Malvern, PA
Biography
Biography of Zhiyang Zhao
Zhiyang Zhao received his Ph.D. degree in Medicinal Chemistry from Virginia Tech, Blacksburg, Virginia, USA. Dr. Zhao’s biopharmaceutical/pharmaceutical work experience encompasses over 25 years of research in metabolic and pharmacokinetic properties of compounds for drug discovery and development at Pfizer, GlaxoSmithKline and Amgen. Currently, Dr. Zhao serves as Chief Scientific Officer (CSO) at Alliance Pharma, Inc. and is appointed as an adjunct professor at the School of Pharmacy, the University of North Carolina at Chapel Hill. Dr. Zhao has published over 50 peer-reviewed original research papers and patents in the areas of new drug targets, drug metabolism, pharmacokinetics, and toxicology.
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Drug Metabolism Letters was launched in 2007. Dr. Zhiyang Zhao serves as the Editor-in-Chief of the journal.
Webmaster Contact: info@benthamscience.net